Clinical trial
Identifying Post ICU Morbidity in Patients With ARDS in the United States
NCT06272942 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identifying Post ICU Morbidity in Patients With ARDS in the United States
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2024
- Completion date
- March 31, 2026
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute respiratory distress syndrome (ards), post intensive care syndrome (pics)